Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROZANOLIXIZUMAB vs SACCHAROMYCES CEREVISIAE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROZANOLIXIZUMAB vs SACCHAROMYCES CEREVISIAE: Safety Overview

Metric ROZANOLIXIZUMAB SACCHAROMYCES CEREVISIAE
Total FAERS Reports 303 284
Deaths Reported 9 85
Death Rate 3.0% 29.9%
Hospitalizations 114 159
Average Patient Age 61.3 yrs 62.1 yrs
% Female Patients 60.9% 59.4%
Manufacturer UCB, Inc. DNA Labs, Inc.
Route SUBCUTANEOUS SUBLINGUAL